NCT05411029Recruiting
Study of Disrupted Sleep in Somali Americans
Disrupted Sleep in Somali Americans - Implications for Hypertension Risk
Source: ClinicalTrials.gov · Last updated 14 Sept 2026
Brief summary (registry, in English)
The aims of this study are to determine the types and severity of previously undiagnosed sleep deficiencies in otherwise healthy Somali Americans, apply a research framework to define psychosocial, behavioral, environmental, and biological mechanisms mediating sleep deficiencies in Somali Americans, and examine the relationship between sleep deficiencies and increased blood pressure in Somali Americans.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 240 (estimated)
- First submitted
- 6 Jun 2022
- Start date
- 15 Nov 2022
- Primary completion date
- Oct 2028
- Lead sponsor
- Mayo Clinic
- Diseases
- High blood pressure
- NCT number
- NCT05411029
What you commit to
- Study type: Observational
- Planned participants: 240
- From 15 Nov 2022 to the primary completion date, Oct 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Anyone under 18 years or over 70 years.
- Positive pregnancy.
Who the study is looking for
- Subjects diagnosed with no known history of hypertension, diabetes, or sleep disorders.
- Self-identify as Somali.
- Adult males and females who are older than 18 years of age.
Age in the registry: 18 years to 70 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Mayo Clinic in Rochester Coordinator of this site? Confirm its status | Rochester | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.